Psilocybin
Psilocybin is a pharmaceutical drug with 171 clinical trials. Currently 75 active trials ongoing. Historical success rate of 93.2%.
Success Metrics
Based on 55 completed trials
Phase Distribution
Phase Distribution
75
Early Stage
80
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
78.6%
55 of 70 finished
21.4%
15 ended early
75
trials recruiting
171
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Neural and Physiological Correlates of Psychedelic Sub-states
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Effects of Repeated Psilocybin Dosing in OCD
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Clinical Trials (171)
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Neural and Physiological Correlates of Psychedelic Sub-states
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Effects of Repeated Psilocybin Dosing in OCD
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Psilocybin Therapy for Depression in Parkinson's Disease
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
Psilocybin as a Novel Therapy for Residual Anhedonia
Psilocybin-Assisted Therapy
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
Psilocybin-assisted CBT for Depression
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Psilocybin-facilitated Treatment for Cocaine Use
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer
Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 171